flunisolide Inhalation solution 1 mg/ ml

A pharmaceutical manufacturer focused on high-complexity and rare-disease care, supplying pharmaceutical products for low-prevalence conditions such as inherited metabolic disorders and tuberculosis, alongside a growing line of OTX and nutraceutical pharmaceutical products for areas including cardiometabolic, neuro-geriatric, respiratory, cellular oxidation, and aesthetic/vascular medicine. The company combines ethical prescription medicines with foods for special medical purposes to support long-term patient management, and highlights a quality culture where raw materials are selected to meet ISO/GMP standard requirements across its pharmaceutical products portfolio.